Wolverine Asset Management’s Raptor Pharmaceutical RPTP Stock Holding History
Bought
Maintained
Sold
Wolverine Asset Management's RPTP Position: Q4 2016 in Review
Wolverine Asset Management sold out of Raptor Pharmaceutical (RPTP) in Q4 2016, closing a stake of 9,400 shares — an estimated $84K sold.
Wolverine Asset Management first reported a position in RPTP in Q3 2016 and held it in 1 quarter. The position peaked at $84K in Q3 2016. 0 funds tracked by Wall St. Rank hold RPTP as of Q4 2016.
- Wolverine Asset Management reported no remaining Raptor Pharmaceutical position as of Q4 2016 after selling out during the quarter.
- Wolverine Asset Management sold 9,400 Raptor Pharmaceutical shares in Q4 2016, an estimated $84K.
- Wolverine Asset Management first reported a position in Raptor Pharmaceutical in Q3 2016 and held it in 1 quarter.
- Wolverine Asset Management's Raptor Pharmaceutical position peaked at $84K in Q3 2016.
- 0 funds tracked by Wall St. Rank held Raptor Pharmaceutical as of Q4 2016.
Based on Wolverine Asset Management's 13F filing for Q4 2016, filed 13 Feb 2017.